Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy
Status: | Recruiting |
---|---|
Conditions: | Breast Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 2/9/2019 |
Start Date: | January 2006 |
End Date: | December 2020 |
Contact: | Nimmi Ramanujam, Ph.D. |
Phone: | (919) 660-5307 |
The objective of the proposed research is to develop new diagnostic modalities based on
optical spectroscopy (auto fluorescence, absorption, and scattering) for the diagnosis of
breast cancer and test its performance as an adjunct to core needle biopsy. For the surgery
part of the study, all patients scheduled to have a mastectomy or lumpectomy for the
treatment of breast cancer will be asked if they would be willing to participate in this
study. For the core needle biopsy part of the study, patients with a higher pre-probability
of cancer (based on mammography) will be recruited to increase the number of patients with
malignant lesions and enrolled in this investigation.
optical spectroscopy (auto fluorescence, absorption, and scattering) for the diagnosis of
breast cancer and test its performance as an adjunct to core needle biopsy. For the surgery
part of the study, all patients scheduled to have a mastectomy or lumpectomy for the
treatment of breast cancer will be asked if they would be willing to participate in this
study. For the core needle biopsy part of the study, patients with a higher pre-probability
of cancer (based on mammography) will be recruited to increase the number of patients with
malignant lesions and enrolled in this investigation.
Inclusion Criteria:
- Patients having a needle biopsy of a breast mass
Exclusion Criteria:
We found this trial at
1
site
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials